» Articles » PMID: 10023636

Cardiovascular Complications in Patients with Primary Aldosteronism

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 1999 Feb 19
PMID 10023636
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Primary aldosteronism (PA) is widely believed to be a relatively benign form of hypertension associated with a low incidence of vascular complications. However, several recent studies showed that cardiovascular complications were not rare in PA. PA is known as one of the most typical forms of sodium-sensitive hypertension. Recently, we found that the sodium sensitivity of blood pressure was a marker for greater risk for cardiovascular complications, especially stroke, in patients with essential hypertension. Therefore, we investigated cardiovascular complications in 58 patients with PA confirmed to be Conn's adenoma. Cardiovascular complications were found in 34% of 58 patients. Coronary artery disease was found in only one patient (1.7%), as angina pectoris. Stroke was found in nine patients (15.5%), four patients (6.9%) with cerebral infarctions and five patients (8.6%) with cerebral hemorrhages. Proteinuria and renal insufficiency were found in 14 (24.1%) and 4 (6.9%) patients, respectively. The incidence of cerebral infarction and renal insufficiency was greater in men than women. The prevalence of proteinuria was greater in patients with than without stroke (P = 0.03) among those aged older than 40 years. These results indicated that cardiovascular complications, especially stroke and proteinuria, were common in patients with PA, and proteinuria might be an indicator for stroke as target-organ damage.

Citing Articles

Transient Ischaemic Attack in a Patient With Conn Syndrome: A Case Report and Literature Review on the Importance of Identifying Secondary Hypertension.

Lee D, Emblin K, Daniels R, Kallis T, Alallan M, Mokbel K In Vivo. 2024; 39(1):566-571.

PMID: 39740894 PMC: 11705155. DOI: 10.21873/invivo.13861.


Image-based computer modeling assessment of microwave ablation for treatment of adrenal tumors.

Sebek J, Cappiello G, Rahmani G, Zeinali N, Keating M, Fayemiwo M Int J Hyperthermia. 2022; 39(1):1264-1275.

PMID: 36137605 PMC: 9820798. DOI: 10.1080/02656736.2022.2125590.


Primary Aldosteronism and Ischemic Heart Disease.

Patil S, Rojulpote C, Amanullah A Front Cardiovasc Med. 2022; 9:882330.

PMID: 35677685 PMC: 9168042. DOI: 10.3389/fcvm.2022.882330.


Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study.

Fernandez-Argueso M, Pascual-Corrales E, Bengoa Rojano N, Garcia Cano A, Jimenez Mendiguchia L, Araujo-Castro M Endocrine. 2021; 73(2):439-446.

PMID: 33797699 DOI: 10.1007/s12020-021-02704-2.


Oral Salt Loading Test is Associated With 24-Hour Blood Pressure and Organ Damage in Primary Aldosteronism Patients.

Yoshida Y, Yoshimura S, Kinoshita M, Ozeki Y, Okamoto M, Gotoh K J Endocr Soc. 2020; 4(10):bvaa116.

PMID: 32968702 PMC: 7497815. DOI: 10.1210/jendso/bvaa116.